Get started
Author

Chetan M. Detroja

Observed names: CHETAN M. DETROJA, Chetan DETROJA, Chetan Detroja
Institution: RK University
ORCID: 0000-0001-7855-2671
Observed ORCID: 0000-0001-7855-2671
OpenAlex ID: A5002314753
Enhanced Antihypertensive Activity of Candesartan Cilexetil Nanosuspension: Formulation, Characterization and Pharmacodynamic Study
2011 · Chetan DETROJA, Sandip Chavhan, et al. · Scientia Pharmaceutica · 86
PDF
Formulation of Mesalamine-loaded Rectal Mucoadhesive Pellets for the Treatment of Inflammatory Bowel Disease Using 32full Factorial Design
2022 · PAYAL N. VAJA, CHETAN M. DETROJA · International Journal of Applied Pharmaceutics · 4
PDF
Formulation and Development of Stable Metaxalone Nanosuspension Using 32 Factorial Design
2016 · Paras R. Vasanani, L. D. Patel, et al. · International Journal of Pharmaceutical Sciences and Drug Research · 3
PDF
Formulation and Characterization of Raloxifene loaded Biodegradable Polymeric Nanomicelles
2023 · Pooja Dave, Chetan Detroja · International Journal of Drug Delivery Technology · 2
PDF
Thermosensitive Copolymeric PLGA-PEG-PLGA Nanomicelles of Raloxifene: Synthesis, Formulation, and In-vitro Characterization
2023 · Pooja Dave, Chetan Detroja · International Journal of Pharmaceutical Sciences and Drug Research · 1
PDF
Dual-component stearoyl polyoxyl-32 glyceride clay composites for enhanced curcumin solubility, stability, and antimicrobial activity
2026 · Prashant B. Gurav, Chetan M. Detroja · International Journal of Drug Delivery Technology
PDF
Enhancement of Dissolution of BCS Class IV Drugs Lopinavir and Ritonavir via Top-Spray Granulation: A QbD Approach
2026 · Brijesh Ray, Chetan Detroja · International Journal of Drug Delivery Technology
PDF
Controlled Release Matrix Formulation of Paliperidone in Concurrence with Regulatory Requirements
2023 · DEEPAK MAHESHWARI, Chetan Detroja · International Journal of Pharmaceutical Sciences and Drug Research
PDF
Works count: 9
Citation count: 96
H-index: 3
I10-index: 1
Year
Topic
Type